Allworth Financial LP Sorrento Therapeutics, Inc. Transaction History

Allworth Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$0.74 - $1.83 $1,387 - $3,431	-1,875 Reduced 78.78%	505 $0
Q3 2022 Oct 18, 2022	BUY	$1.51 - $2.88 $3,593 - $6,854	2,380 New	2,380 $4,000
Q2 2022 Jul 13, 2022	SELL	$1.24 - $2.33 $1,240 - $2,330	-1,000 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$4.65 - $7.23 $465 - $723	-100 Reduced 9.09%	1,000 $5,000
Q3 2021 Nov 02, 2021	BUY	$7.41 - $10.99 $7,410 - $10,990	1,000 Added 1000.0%	1,100 $8,000
Q4 2020 Jan 26, 2021	BUY	$5.76 - $11.95 $576 - $1,195	100 New	100 $1,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.